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Conclusions Patients affected by T1DM have a worse 
exercise tolerance than normal subjects. The two groups 
differed by RER which can be greatly influenced by the 
substrate type utilized to produce energy. Because of the 
impaired carbohydrate utilization, T1DM subjects may use 
a larger amount of lipid substrates, such hypothesis could 
be strengthened by the lower lactate levels found in T1DM 
group at peak exercise. The lack of correlation between 
exercise tolerance and disease-related variables suggests 
that the alterations found could be independent from the 
glycemic levels.
Keywords Diabetes mellitus · Exercise physiology · 
Physical activity · Cardiopulmonary exercise test
Introduction
Type-1 diabetes mellitus (T1DM) is a chronic disease 
characterized by chronic hyperglycemia and induced by 
immuno-mediated or idiopathic beta-cell destruction, 
which leads to lack of insulin production [1].
Treatment goals are prevention of microvascular and 
macrovascular complications, which are linked to chronic 
hyperglycemia and to the complex metabolic alterations 
associated with diabetes [2].
Insulin administration, generally with a basal-bolus pro-
tocol, represents the baseline treatment of T1DM. Anyhow, 
an optimal disease treatment should include a comprehen-
sive intervention on cardiovascular risk factors (hyperten-
sion, dyslipidemia, obesity, and smoking), integrating phar-
macological treatment and lifestyle changes.
Physical activity is an effective therapeutic tool for pre-
venting cardiovascular risk in the general population, as 
well as in subjects with type-2 diabetes [3, 4]. Despite this, 
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only few studies addressing the role of physical activity as 
a therapeutic strategy for T1DM have been performed up to 
2011 [5].
Bohn et  al. have recently demonstrated an association 
between physical activity and glycosylated hemoglobin 
(HbA1c), body mass index (BMI), dyslipidemia, hyperten-
sion, as well as between physical activity and retinopathy or 
microalbuminuria [6]. However, there is no agreement on 
the exercise aerobic capacity of patients with T1DM. Some 
studies did not find any difference in comparison to healthy 
subjects [7–9], while other authors found a reduced exer-
cise aerobic capacity in T1DM subjects [10–13]. In these 
last studies, patients with T1DM showed reduced oxygen 
uptake at exercise peak (VʹO2max). Data from the Study of 
Health in Pomerania (SHIP) [14] confirmed a reduced exer-
cise tolerance in adults with type 1 diabetes (mean age 50 
years), showing a reduced VʹO2max and oxygen uptake at 
anaerobic threshold when compared to a matched popula-
tion without type 1 diabetes. The authors speculate about 
a possible correlation with clinical status (metabolic, car-
diac, respiratory, and peripheral vascular disease) and exer-
cise performance, but the results could not be thoroughly 
explained. Moreover, the metabolic response to physical 
activity in T1DM is still not clearly defined, since most of 
the studies have been performed in strictly controlled con-
ditions, such as clamp techniques [15, 16], or after insu-
lin withdrawal [17] which cannot be applied to real-life 
models.
Aim of the current study is to evaluate exercise aerobic 
capacity in patients with T1DM in basal-bolus insulin ther-
apy, compared to a healthy control population.
The relationship between exercise tolerance and pre-test 
glycaemia, and glycosylated hemoglobin and diabetes dura-
tion was also assessed.
Materials and methods
This observational preliminary study included 17 con-
secutive T1DM patients presenting between November 
2014 and May 2015 to the Diabetic Center of the Univer-
sity Hospital Policlinico Umberto I, Rome; type 1 diabe-
tes was diagnosed according to the American Diabetes 
Association (ADA) guidelines [1] in basal-bolus treatment, 
aged between 18 and 45 years, with a diabetes history of 
less than 15 years (to reduce the chance of comorbidi-
ties), HbA1c < 75  mmol/L. As control group, 17 healthy 
volunteers matched for age, sex, BMI, and physical activ-
ity level were enrolled. Exclusion criteria were: patients 
unable or with contraindications to perform an exercise 
test; HbA1c ≥ 75  mmol/L; diabetic ketoacidosis; macro-
vascular complications; proliferative diabetic retinopathy; 
respiratory diseases (COPD, asthma, and interstitial lung 
diseases); anemia; hypothyroidism or hyperthyroidism; 
pregnancy or lactation; menopause; clinical evidence or 
history of cancer; and medication (other than insulin). The 
presence of exclusion criteria was evaluated using medical 
records and the latest blood tests available.
Written informed consent was obtained from each sub-
ject. The study was approved by the Internal Review Board 
(IRB) and the local Ethics Committee and was performed 
according to the principles of the Declaration of Helsinki 
(1975).
Clinical assessment, blood pressure, heart rate, oxygen 
saturation, and anthropometric data (weight, height, and 
BMI) were obtained from each subject. All subjects com-
piled the International Physical Activity Questionnaire 
(IPAQ) to assess physical activity level [18].
A venous catheter was positioned to collect blood sam-
ples at rest and at peak exercise, for evaluation of blood 
glucose and lactate levels; collected samples were analyzed 
using a blood gas analyzer (GEM Premier 4000—Instru-
mentation Laboratory Worldwide Headquarters, Bedford, 
MA).
Before exercise testing, all subject performed a pulmo-
nary function test with a  Quark® PFT (COSMED, Pavona, 
Italy).
Cardiopulmonary exercise test (CPET) was conducted 
on an electronically-braked cycle ergometer (COSMED, 
Pavona Italy) using the Quark b 2 system (COSMED, 
Pavona, Italy) according to guidelines [19]. CPET con-
sisted of a steady-state resting period, then 1 min of warm-
up without load, followed by a stepwise protocol in which 
the work rate was increased in 1-min intervals by incre-
ments of 15  W. The test was continued until the point of 
symptom limitation (peak exercise). Subjects were asked 
to score their sense of breathlessness and muscle fatigue 
throughout the exercise and at peak exercise using Borg 
scale [20]. Oxygen saturation  (SpO2) by pulse oximetry, 
electrocardiographic monitoring of heart rate (HR), blood 
pressure (BP), oxygen uptake (VʹO2), carbon dioxide pro-
duction (VʹCO2), and minute ventilation (VʹE) were col-
lected. Ventilation was compared with the maximal ventila-
tory capacity (MVC), which was estimated by multiplying 
the measured FEV 1 (forced expiratory volume in 1 s) by 
40 [21]. The Lactic Threshold (LT) was detected individu-
ally using the V-slope method [22]. The ventilatory com-
pensation point (VCP) estimation was based on VʹE/VʹCO2 
relationship, where VʹE started to change out of propor-
tion of VʹCO2 and  PETCO2 [19]. The exercise test was con-
sidered maximal for a value of respiratory exchange ratio 
(RER) >1.05. All cardiopulmonary exercise tests were exe-
cuted and interpreted by two expert operators.
All the tests were performed in the morning, after break-
fast. T1DM patients did not modify their usual insulin 
dose, based on carbohydrate count or fasting glucose levels. 
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Subjects were also asked to avoid the ingestion of alcohol 
caffeine-containing products and to refrain from strenu-
ous activity for at least 12 h before testing. Glucose levels 
were measured before the test, at peak exercise and in case 
of symptoms of hypoglycemia. Exercise test was not per-
formed if pre-test blood glucose was less than 5.56 mmol/L 
or greater than 13.9 mmol/L [23].
Statistical analysis
Considering the small sample size and the non-Gaussian 
distribution of the study population, non-parametric tests 
were applied. Results are expressed as median and range. 
Groups were compared using Kruskal–Wallis test. Bivari-
ate correlation analysis was performed using Spearman 
coefficient. Statistical analysis was performed using the 
SPSS statistical software, version 22 (SPSS Inc.—Chicago, 
IL). Results were considered statistically significant for a p 
value <0.05.
Results
Anthropometric and metabolic parameters of T1DM and 
healthy subjects are reported in Table  1. There is a non-
statistically significant difference of age between the two 
groups; however, such a difference is attenuated by the 
use of the Hansen–Wasserman formula [24] to estimate 
the predicted values for VʹO2,peak, which applies a value of 
30 years for subjects younger than 30 years, thus reducing 
age difference in expected VʹO2,peak values. CPET results 
are shown in Table  2. All subjects performed a maximal 
CPET (RER > 1.05). Diabetic subjects reached a maximum 
workload (W max) of 165 ± 9.7 W, while healthy subjects 
reached a maximum load of 198 ± 6.9  W. The difference 
was statistically significant (p = 0.007).
Mean oxygen uptake at peak exercise (VʹO2,peak) 
was significantly (p = 0.035) lower in T1DM subjects 
with absolute value of 2220 ± 132  ml/min and a value of 
28.1 ± 1.3 ml/min/kg when corrected by body weight (79% 
of the predicted theoretical value). Healthy subjects had 
an oxygen uptake of 2659 ± 120 ml/min and 35.5 ± 1.1 ml/
min/kg (87% of the predicted theoretical value). Consider-
ing a normal threshold of 80% of predicted value 11 dia-
betic patients (64%) and 8 healthy volunteers (47%) had 
reduced exercise tolerance (Table 2; Fig. 1). No ventilatory 
limitation was found in both groups (Table 2). Cardiovas-
cular response analysis did not show statistically signifi-
cant differences for heart rate (pre-test, at peak exercise and 
during recovery) and chronotropic response, expressed as 
heart rate to oxygen uptake ratio (HR/VO2) (Table 2). No 
arrhythmic or ischaemic events were observed. Anaero-
bic threshold was reached at 45 ± 1.5% of predicted theo-
retical VʹO2,peak by T1DM subjects and at 47 ± 2.8% by 
healthy subjects. Pre-test RER values were similar in the 
two groups, but significantly higher in healthy subjects at 
peak exercise and at the first recovery minute (p = 0.022, 
p = 0.024) (Fig. 2).
Laboratory tests
There was no difference in the pre-test lactate levels, though 
peak exercise lactate levels were significantly higher in 
healthy subjects (p = 0.027). Blood glucose levels were sig-
nificantly higher in T1DM group (p = 0.000), as expected, 
and remained stable throughout the whole duration of the 
test. No hypoglycemic events were reported (Table 3).
Table 1  Anthropometric and 
metabolic parameters
Study groups had similar anthropometric characteristics
IPAQ International Physical Activity Questionnaire, NPDR non-proliferative diabetic retinopathy
Non-T1DM (17) T1DM (17) p
Age (years) 27 (±1.2) 34 (±1.8) ns
Sex (M/F) 13/4 13/4 ns
BMI (Kg/m²) 23.6 (±0.4) 23.5 (±0.7) ns
Smokers 9 6 0.03
IPAQ (moderate/high) 11/6 10/7 ns
Pre-test glucose (mmol/l) 5.17 (±0.18) 10.67 (±1.123) <0.001
HbA1c (mmol/l) 57 (±2.4)
Diabetes duration (years) 10 (±1.1)
Insulin (UI/Kg) 0.4 (±0.03)
Time from insulin administration (min) 140 (±9)
Insulin type (rapid-acting/human regular) 14/3
Retinopathy 3 NPDR
Albuminuria 1
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There was no statistical correlation between CPET 
results and diabetes-related parameters (i.e., diabetes dura-
tion, HbA1c level, pre-test and peak exercise blood glu-
cose, and insulin requirement).
Discussion
This preliminary study shows a statistically significant 
different exercise tolerance in diabetic subjects when 
expressed as VʹO2,peak, compared to a population of sub-
jects matched for age, anthropometric parameters, and 
training level. The selection of young subjects, with rela-
tively short duration of diabetes (<15 years), with accept-
able metabolic control, reduced the possible confounding 
factors.
Cardiovascular diseases (CVD) are the most fre-
quent cause of death in T1DM, with ten-fold increased 
CVD-related and all-cause mortality compared with the 
general population [25, 26]. Diabetic patients develop 
Table 2  Metabolic, ventilatory, 
and cardiovascular response
VʹO2 oxygen uptake, VʹO2,peak oxygen uptake at peak exercise, VʹO2 LT oxygen uptake at lactate threshold, 
VE minute ventilation, HR heart rate, SBP systolic blood pressure, DBP diastolic blood pressure
Non-T1DM (17) T1DM (17) p
Watt max (W) 198 (±6.9) 165 (±9.7) <0.007
VʹO2,peak (ml/min) 2659 (±120) 2220 (±132) 0.035
VʹO2,peak/Kg (ml/min/Kg) 35.5 (±1.1) 28.1 (±1.3) 0.017
VʹO2,peak (% predicted) 87 (±2.5) 79 (±2.8) 0.022
VʹO2 LT/VO2max (% predicted) 47 (±2.8) 45 (±1.5) ns
VʹO2/W slope 10.5 (±0.4) 10.1 (±0.2) ns
Borg rest/peak 0/4 (±0.7) 0/5 (±0–5) ns
Leg rest/peak 0/7 (±0.5) 0/5 (±0.5) ns
Breathing reserve(%) 56 (±2.9) 58 (±2.9) ns
SpO2 rest/peak (%) 99 (±0.1)/98 (±0.2) 98 (±0.1)/98 (±0.2) ns
VE/VCO2 slope 22.4 (±0.6) 22.9 (±0.6) ns
HR rest/peak (bpm) 80 (±2.3)/170 (±2.9) 87 (±4.4)/162 (±4.1) ns
HR peak (bpm) 170 (±2.9) 162 (±4.1) ns
SBP/DBP rest (mmHg) 120 (±2.9)/80 (±1.4) 120 (±2.6)/70 (±1.9) ns
SBP/DBP peak (mmHg) 190 (±5.7)/80 (±2.4) 180 (±4.4)/80 (±2.6) ns
Fig. 1  Oxygen uptake (VʹO2) 
in basal condition, at anaerobic 
threshold and at peak exercise. 
The two groups had a similar 
oxygen uptake at baseline; VʹO2 
was higher in subjects without 
type 1 diabetes at anaerobic 
threshold, but the difference 
was not statistically significant. 
Oxygen uptake was significantly 
lower in type 1 diabetes patients 
at peak exercise (p = 0.035)
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atherosclerotic damage earlier than healthy subjects. Physi-
cal activity may play a pivotal role because of the possible 
action on multiple risk factors and positive effects on qual-
ity of life.
The pathophysiological mechanisms underlying meta-
bolic and cardiovascular modifications in T1DM subjects 
have not been completely understood; furthermore, indi-
vidual response to physical activity may be unpredictable.
The risk of hypoglycemic events frequently discourages 
physical activity in type 1 diabetic patients [26, 27] and up 
to 60% of diabetic patients do not perform a regular physi-
cal activity to avoid hypoglycemic events.
Our findings have excluded, in the present popula-
tion, ventilatory limitations to physical exercise, as well 
as hemodynamic limitations and ischemic or arrhythmic 
events. The two groups differed by respiratory ratio (RER, 
the relationship between  CO2 produced and  O2 consumed) 
which can be greatly influenced by the substrate type 
utilized to produce energy [28, 29]. A lower RER is gen-
erally associated with prevalent lipid substrate utilization. 
Lower levels of lactate and pyruvate have been described in 
T1DM patients during exercise test [30]. Plasmatic levels 
of lactate and pyruvate depend on glycogenolysis, which 
relies on anaerobic glycolysis [31]. Persistently high plas-
matic insulin levels may inhibit the glycolytic response in 
diabetic patients, interfering with the production of sub-
strates in the tricarboxylic acid cycle, which is very impor-
tant for early energy production during physical activity 
[11, 32].
Because of the impaired carbohydrate utilization, T1DM 
subjects may use a larger amount of lipid substrates, such 
hypothesis could be strengthened by the lower lactate levels 
found in T1DM group at peak exercise.
The lack of correlation between exercise tolerance and 
disease-related variables suggests that the alterations found 
could be independent from the glycemic levels and more 
probably linked to the complex underlying hormonal and 
metabolic alterations of T1DM. Stubbe et al. [14] did not 
find an association with HbA1c and exercise parameters as 
well.
There is a statistically significant difference in smoking 
habit between the two groups that could be a limit of the 
study. Anyhow, the most important limitations of the study 
come from small sample size and a male/female sex ratio 
favoring the former. A further limit of the study is repre-
sented by the use of IPAQ questionnaire to assess physi-
cal activity level, which is a self-reported questionnaire that 
may lack objectivity. Another possible confounding factor 
may be represented by the absence of a standardized meal 
for T1DM group, with a slightly different time interval 
between insulin administration and test execution; anyhow, 
Fig. 2  Respiratory exchange 
ratio during exercise and 
recovery. RER was lower in 
type 1 diabetic subjects during 
the whole exercise test and 
recovery. The differences were 
statistically significant at peak 
exercise and at the first minute 
of recovery. RER respiratory 
exchange ratio, Rec1 first min-
ute of recovery, Rec2 second 
minute of recovery, Rec4 fourth 
minute of recovery
Table 3  Glucose and lactate levels
Glucose levels remained stable for all the duration of the test in both 
groups. Subjects with type 1 diabetes produced statistically signifi-
cant lower levels of lactate, compared to normal subjects
Non-T1DM (17) T1DM (17) p
Pre-test glucose (mmol/l) 5.17 (±0.18) 10.67 (±13) 0.000
Peak exercise glucose 
(mmol/l)
4.83 (±0.14) 10.39 (±0.72) 0.000
Δglucose (peak-pre) 
(mmol/l)
0 (±0.24) −0.06 (±0.43) ns
Pre-test lactate (mmol/l) 0.14 (±0.01) 0.14 (±0.01) ns
Peak exercise lactate 
(mmol/l)
0.62 (±0.06) 0.44 (±0.04) 0.027
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a changing in the subject’s usual meal could have produced 
unexpected glycemic variations and could have required 
insulin dose adjustments.
Conclusions
Patients affected by type 1 diabetes mellitus have a worse 
exercise tolerance than healthy subjects with similar anthro-
pometric characteristics and training level. Such alteration 
seems to be linked to different metabolic substrate utiliza-
tion. Further studies are, however, needed to fully under-
stand the complex network of T1DM metabolic alterations.
Physical activity is a very important therapeutic inter-
vention in chronic diseases because of its pleiotropic effects 
and CPET may help in the development of a personalized 
physical activity program through a better analysis of the 
individual response to exercise test, allowing improved 
compliance to physical activity.
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